C*I
发帖数: 4736 | 1 当南华早报记者询问gilead，remdesivir 已经被中国武汉的病毒研究所抢先注册问题
时，Gilead 负责公共关系的副总裁 Sonia Choi 告诉南华早报说：“这个时候，我们
着重关注的是药能不能救人以及加快生产以满足接下来对它的需要”。
Sonia Choi, Gilead’s vice president of public affairs, said in an email
reply to the South China Morning Post. “Our focus at this time is on
rapidly determining the potential for remdesivir as a treatment for [the
novel coronavirus] and accelerating manufacturing in anticipation of
potential future supply needs.”
而且，药还是免费给的。 |
|
